These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 14703959)

  • 1. Structure-activity relationships of novel anti-malarial agents part 8. Effect of different central aryls in biarylacryloylaminobenzophenones on antimalarial activity.
    Wiesner J; Mitsch A; Altenkämper M; Ortmann R; Jomaa H; Schlitzer M
    Pharmazie; 2003 Dec; 58(12):854-6. PubMed ID: 14703959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of farnesyltransferase: 5-arylacryloylaminobenzophenones show antimalarial activity.
    Wiesner J; Ortmann R; Mitsch A; Wissner P; Sattler I; Jomaa H; Schlitzer M
    Pharmazie; 2003 Apr; 58(4):289-90. PubMed ID: 12749417
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of benzophenone-based farnesyltransferase inhibitors as novel antimalarials.
    Kohring K; Wiesner J; Altenkämper M; Sakowski J; Silber K; Hillebrecht A; Haebel P; Dahse HM; Ortmann R; Jomaa H; Klebe G; Schlitzer M
    ChemMedChem; 2008 Aug; 3(8):1217-31. PubMed ID: 18470859
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-thiol farnesyltransferase inhibitors: N-(4-aminoacylamino-3-benzoylphenyl)-3-[5-(4-nitrophenyl)-2 furyl]acrylic acid amides and their antimalarial activity.
    Kettler K; Wiesner J; Silber K; Haebel P; Ortmann R; Sattler I; Dahse HM; Jomaa H; Klebe G; Schlitzer M
    Eur J Med Chem; 2005 Jan; 40(1):93-101. PubMed ID: 15642414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimalarial activity of methylpiperazinyl-substituted benzophenone-based farnesyltransferase inhibitors.
    Kettler K; Wiesner J; Ortmann R; Dahse HM; Jomaa H; Schlitzer M
    Pharmazie; 2006 Jan; 61(1):63-5. PubMed ID: 16454209
    [No Abstract]   [Full Text] [Related]  

  • 6. 2-(aminoacylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
    Kettler K; Wiesner J; Fucik K; Sakowski J; Ortmann R; Dahse HM; Jomaa H; Schlitzer M
    Pharmazie; 2005 Sep; 60(9):677-82. PubMed ID: 16222868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-thiol farnesyltransferase inhibitors: utilization of the far aryl binding site by 5-cinnamoylaminobenzophenones.
    Mitsch A; Wissner P; Böhm M; Silber K; Klebe G; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Sep; 337(9):493-501. PubMed ID: 15362122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 2-(Arylpropionylamino)- and 2-(arylacryloylamino)benzophenones: farnesyltransferase inhibition and antimalarial activity.
    Fucik K; Kettler K; Wiesner J; Ortmann R; Unterreitmeier D; Krauss J; Bracher F; Jomaa H; Schlitzer M
    Pharmazie; 2004 Oct; 59(10):744-52. PubMed ID: 15544051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-thiol farnesyltransferase inhibitors: FTase-inhibition and cellular activity of benzophenone-based bisubstrate analogue farnesyltransferase inhibitors.
    Mitsch A; Bergemann S; Gust R; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2003 Jul; 336(4-5):242-50. PubMed ID: 12916059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-thiol farnesyltransferase inhibitors: utilization of the near aryl binding site by 5-arylacetylaminobenzophenones.
    Mitsch A; Böhm M; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2004 Apr; 337(4):213-8. PubMed ID: 15065081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships of novel anti-malarial agents: 1. arylacyl and cyclohexylacyl derivatives of 5-amino-2-tolylacetylaminobenzophenone.
    Wiesner J; Mitsch A; Wissner P; Jomaa H; Schlitzer M
    Pharmazie; 2001 Jun; 56(6):443-4. PubMed ID: 11446161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability.
    Carrico D; Ohkanda J; Kendrick H; Yokoyama K; Blaskovich MA; Bucher CJ; Buckner FS; Van Voorhis WC; Chakrabarti D; Croft SL; Gelb MH; Sebti SM; Hamilton AD
    Bioorg Med Chem; 2004 Dec; 12(24):6517-26. PubMed ID: 15556768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel lead structures for antimalarial farnesyltransferase inhibitors.
    Kettler K; Sakowski J; Wiesner J; Ortmann R; Jomaa H; Schlitzer M
    Pharmazie; 2005 May; 60(5):323-7. PubMed ID: 15918578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structure-activity relationships of novel anti-malarial agents. Part 7: N-(3-benzoyl-4-tolylacetylaminophenyl)-3-(5-aryl-2-furyl)acrylic acid amides with polar moieties.
    Wiesner J; Mitsch A; Jomaa H; Schlitzer M
    Bioorg Med Chem Lett; 2003 Jul; 13(13):2159-61. PubMed ID: 12798326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protein farnesyltransferase inhibitors exhibit potent antimalarial activity.
    Nallan L; Bauer KD; Bendale P; Rivas K; Yokoyama K; Hornéy CP; Pendyala PR; Floyd D; Lombardo LJ; Williams DK; Hamilton A; Sebti S; Windsor WT; Weber PC; Buckner FS; Chakrabarti D; Gelb MH; Van Voorhis WC
    J Med Chem; 2005 Jun; 48(11):3704-13. PubMed ID: 15916422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial and antitrypanosomal activity of a series of amide and sulfonamide derivatives of a 2,5-diaminobenzophenone.
    Altenkämper M; Bechem B; Perruchon J; Heinrich S; Mädel A; Ortmann R; Dahse HM; Freunscht E; Wang Y; Rath J; Stich A; Hitzler M; Chiba P; Lanzer M; Schlitzer M
    Bioorg Med Chem; 2009 Nov; 17(22):7690-7. PubMed ID: 19819706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptidomimetic inhibitors of protein farnesyltransferase show potent antimalarial activity.
    Ohkanda J; Lockman JW; Yokoyama K; Gelb MH; Croft SL; Kendrick H; Harrell MI; Feagin JE; Blaskovich MA; Sebti SM; Hamilton AD
    Bioorg Med Chem Lett; 2001 Mar; 11(6):761-4. PubMed ID: 11277514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-thiol farnesyltransferase inhibitors: structure-activity relationships of aralkylsubstituted benzophenones.
    Mitsch A; Wissner P; Sattler I; Schlitzer M
    Arch Pharm (Weinheim); 2001 Feb; 334(2):40-4. PubMed ID: 11268773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structurally simple farnesyltransferase inhibitors arrest the growth of malaria parasites.
    Glenn MP; Chang SY; Hucke O; Verlinde CL; Rivas K; Hornéy C; Yokoyama K; Buckner FS; Pendyala PR; Chakrabarti D; Gelb M; Van Voorhis WC; Sebti SM; Hamilton AD
    Angew Chem Int Ed Engl; 2005 Aug; 44(31):4903-6. PubMed ID: 16007716
    [No Abstract]   [Full Text] [Related]  

  • 20. Ligand-based virtual screening and in silico design of new antimalarial compounds using nonstochastic and stochastic total and atom-type quadratic maps.
    Marrero-Ponce Y; Iyarreta-Veitía M; Montero-Torres A; Romero-Zaldivar C; Brandt CA; Avila PE; Kirchgatter K; Machado Y
    J Chem Inf Model; 2005; 45(4):1082-100. PubMed ID: 16045304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.